The United States’ federal prison system no longer offers gender-affirming care to incarcerated trans people under a new Bureau of Prisons policy. Signed into effect by Bureau of Prisons (BOP) ...

Conservatives have long argued they want to end transition care for minors, but federal policies have increasingly limited ...

Recent guidance from the Trump administration requires federal prisons to begin reducing transgender inmates’ hormone therapy treatments. Medical experts warn that the move will have dangerous medical ...

Overweight, obesity, and dyslipidaemia were common in transgender adolescents before hormone therapy. Sex steroid therapy affected lipid profiles differently in transgender boys and girls, with trans ...

A new study of the longest-acting form of injectable PrEP, lenacapavir, has shown no adverse interactions with hormone therapy for trans women and men. Marketed under the brand name Yeztugo by Gilead ...

Access to gender-affirming hormone therapy in adolescence is associated with better mental health outcomes for transgender adults, according to a new study. The research, published Wednesday in the ...

More than 20 hospitals and health systems have temporarily or indefinitely rolled back transgender care for minors and some young adults this year amid threats of federal investigations and cuts to ...